Log In
BCIQ
Print this Print this
 

KA2507

  Manage Alerts
Collapse Summary General Information
Company Karus Therapeutics Ltd.
DescriptionHistone deacetylase 6 (HDAC6) inhibitor
Molecular Target Histone deacetylase 6 (HDAC6)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/10/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today